Hardik Shah
2026.06.11 12:35

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: $Tempus AI(TEM.US) Tempus AI Publishes Validation Study for FDA-Cleared ECG-AF Software

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค Tempus AI publishes ๐ฆ๐ฎ๐ฅ๐ญ๐ข-๐ฌ๐ข๐ญ๐ž validation of its ๐„๐‚๐†-๐€๐… software.

โžค Software received ๐…๐ƒ๐€ ๐œ๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž in 2024 for AF risk prediction.

โžค AI model predicts ๐จ๐ง๐ž-๐ฒ๐ž๐š๐ซ risk of atrial fibrillation or flutter.

โžค Study results published in leading cardiology journal ๐‡๐ž๐š๐ซ๐ญ ๐‘๐ก๐ฒ๐ญ๐ก๐ฆ.

โžค Validation conducted across ๐ญ๐ก๐ซ๐ž๐ž geographically distinct clinical sites.

โžค Study evaluated ๐ท4,017 patients aged 65 and older.

โžค ECG-AI risk score exceeded ๐ฉ๐ซ๐ž-๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐ž๐ performance thresholds.

โžค Data from study supported Tempus' ๐…๐ƒ๐€ ๐œ๐ฅ๐ž๐š๐ซ๐š๐ง๐œ๐ž decision.

โžค Tool aims to enable ๐ž๐š๐ซ๐ฅ๐ฒ ๐ซ๐ข๐ฌ๐ค ๐๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง before AF diagnosis.

โžค Tempus says ECG-AF was its first ๐…๐ƒ๐€-๐œ๐ฅ๐ž๐š๐ซ๐ž๐ ECG-AI device.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.